跳至主要内容
临床试验/NL-OMON33420
NL-OMON33420已完成4 期

Short term statin treatment and endothelial dysfunction due to ischemia and reperfusion injury - Statins-IRI-FMD

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age 18-50
  • - Written informed consent

排除标准

  • - History of any cardiovascular disease
  • - Hypertension (in supine position: systole >140 mmHg, diastole >90 mmHg)
  • - Diabetes Mellitus (fasting glucose >7.0 mmol/L or random glucose >11.0 mmol/L)
  • - Hyperlipidemia (fasting total cholesterol >5.5 mmol/L or random cholesterol >6.5
  • - Alanine amino transferase >90 U/L
  • - Creatine kinase >440 U/L
  • - Raised rabdomyolysis risk
  • o GFR <60 ml/min
  • o Overt clinical signs of hypothyroidism
  • o Myopathy in family history
  • o Alcohol abuse
  • - Concomitant chronic use of medication
  • - Participation to any drug-investigation during the previous 60 days as checked with VIP check.

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验